Identifying Soil Cleanup Criteria for Dioxins in Urban Residential Soils: How Have 20 Years of Research and Risk Assessment Experience Affected the Analysis?

This article reviews the scientific evidence and methodologies that have been used to assess the risks posed by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and presents a probabilistic analysis for identifying virtually safe concentrations of TCDD toxicity equivalents (TEQ) in residential soils. Updated data distributions that consider state-of-the-science cancer and noncancer toxicity criteria, child soil ingestion and dermal uptake, bioavailability in soil, and residential exposure duration are incorporated. The probabilistic analysis shows that the most sensitive determinants of dose and risk are childhood soil ingestion, exposure duration, and the selected TCDD cancer potency factor. It also shows that the cancer risk at 1 per 100,000 predicted more conservative (lower) soil criteria values than did the noncancer hazard (e.g., developmental and reproductive effects). In this analysis, acceptable or tolerable soil dioxin concentrations (TCDD TEQ) ranged from 0.4 to 5.5 ppb at the 95th percentile for cancer potency factors from 9600 to 156,000 (mg/kg/d)⁻¹ with site-specific adjustments not included. Various possible soil guidelines based on cancer and noncancer risks are presented and discussed. In the main, the current toxicology, epidemiology, and exposure assessment data indicate that the historical 1 ppb TEQ soil guidance value remains a reasonable screening value for most residential sites. This analysis provides risk managers with a thorough and transparent methodology, as well as a comprehensive information base, for making informed decisions about selecting soil cleanup values for PCDD/Fs in urban residential settings.

This analysis was funded by the Dow Chemical Company, which has been studying PCDD/Fs for more than four decades. The firm has been and is currently involved in litigation related to PCDD/F contaminated soils. Each of the authors has researched the toxicology and risk assessment issues on dioxins for the past 10 to 25 yr and has provided consultations to various industrial, commercial, and governmental clients regarding the underlying science and presented their interpretations in academic, regulatory, and/or litigation settings. Dr. Paustenbach has been and continues to serve as an expert in dioxin litigation involving Dow Chemical Company.

Notes

This analysis was funded by the Dow Chemical Company, which has been studying PCDD/Fs for more than four decades. The firm has been and is currently involved in litigation related to PCDD/F contaminated soils. Each of the authors has researched the toxicology and risk assessment issues on dioxins for the past 10 to 25 yr and has provided consultations to various industrial, commercial, and governmental clients regarding the underlying science and presented their interpretations in academic, regulatory, and/or litigation settings. Dr. Paustenbach has been and continues to serve as an expert in dioxin litigation involving Dow Chemical Company.

Agency for Toxic Substances and Disease Registry. 2005. Updated ATSDR policy guidelines for dioxin and dioxin-like compounds in soil, draft, November 9, 2004. Presented at joint public meeting of the Board of Scientific Counselors, National Center for Environmental Health and ATSDR November 18–19. Available from ATSDR, Atlanta, GA

Cook, P. M., Walker, M. K., Kuehl, D. W., and Peterson, R. E. 1991. Bioaccumulation and toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds in aquatic ecosystems. Madison, WI, and Duluth, MN: U.S. Environmental Protection Agency, Environmental Research Laboratory, Duluth Min, and School of Pharmacy and Environmental Toxicology Center, University of Wisconsin

Kerger, B. D., Paustenbach, D. J., and Richter, R. O. 2005c. Unpublished calculations

Krablin, R. 1989. [Letter to Jonathan Z. Cannon concerning soil ingestion rates.] Denver, CO: Arco Coal Co., October 13 (as cited in U.S. EPA, 1997a)

National Toxicology Program. 1982. Carcinogenesis bioassay of 2,3,7,8-tetrachlorodibenzo-p-dioxin (CAS No. 1746-01-6) in Osborne-Mendel rats and B6C3F1 mice (gavage study). U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health. NTP TR 209

National Toxicology Program. 2004. Draft NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage study) U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health. NTP TR 521

OEHHA Office of Environmental Health Hazard Assessment. 2004. Article 7. No significant risk levels. In Proposition 65 - TITLE 22, Division 2, Part 2, Subdivision 1, Chapter 3, California Code of Regulations, eds

Ontario Ministry of Environment. 1985. Polychlorinated dibenzo-p-dioxins (PCDDs) and polychlorinated dibenzofurans (PCDFs). Scientific criteria document for standard development No. 4–84. Intergovernmental Relations and Hazardous Contaminants Coordination Branch, Ontario, Canada, September

Susten, A. 2004. Personal communication to D. J. Paustenbach. Dr. Susten is a retired scientist formally employed by ATSDR and CDC. The cited statements are based on observations and opinions of Dr. Susten and do not necessarily reflect the opinions or policies of ATSDR or CDC

United Kingdom. 1989. Dioxins in the environment. Report of an interdepartmental working group on polychlorinated dibenzo-para‐dioxins (PCDDs) and polychlorinated dibenzofurans (PCDFs). Pollution Paper no. 27. Central Directorate of Environmental Protection

U.S. Environmental Protection Agency. 1989a. Integrated Risk Information System (IRIS) on-line database entry for 2,3,7,8-tetrachlorodibenzo-p-dioxin. January 1

U.S. Environmental Protection Agency. 1997c. Memorandum from Deputy Administrator Fred Hansen on the use of probabilistic techniques (including monte carlo analysis in risk assessment and guiding principles for Monte Carlo analysis). Washington, DC

U.S. EPA. 1991. Percutaneous absorption of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and 3,3’4,4’-tetrachlorobiphenyl (TCB) applied in soil. Office of Health and Environmental Assessment. Available from Exposure Assessment Group, Washington, DC. OHEA-E-453

U.S. Food and Drug Administration. 1983. Statement by Sanford A. Miller, Ph.D., Director, Bureau of Foods, Food and Drug Administration, before the Subcommittee on Natural Resources, Agriculture, Research and Environment, Committee on Science and Technology, U.S. House of Representatives, June 30

World Health Organization. 1991. Consultation on tolerable daily intake from food of PCDDs and PCDFs. Copenhagen, Denmark. Summary Report. Bilthoven, Netherlands. EUR/IPC/PCS 030(S). December 4–7, 1990